-
Think about the last five women who have entered your examination room. How many of them have had genital herpes simplex virus Type 2 (HSV-2) infection?
-
Two years after the government implemented routine HIV testing for all patients ages 13-64 without regard to risk, public health officials say improvements have been made, yet still one in five people infected with the AIDS virus is unaware of his/her status.
-
How many of your patients rely on vasectomy for contraception? About 500,000 vasectomies are performed each year in the United States; about one out of six U.S. men over age 35 has been vasectomized, with prevalence increasing with education and income.
-
Results from a Phase III study in men ages 16 to 26 indicate that the human papillomavirus (HPV) vaccine Gardasil (Merck & Co.) prevented 90% of external genital lesions caused by types 6, 11, 16, and 18 of HPV.
-
Good news: About 75% of respondents to the 2008 Contraceptive Technology Update Salary Survey say they received increases in their paychecks in the last year. Bad news: The majority (57%) saw only a 1%-3% increase.
-
Results from a just-published study indicate that teens who are treated for pelvic inflammatory disease (PID) are at risk for subsequent sexually transmitted infections (STIs) and/or PID for 48 months.1 What can clinicians do to stem subsequent infection?
-
When it comes to current methods of delivery of hormonal contraception, women now can choose among pill, patch, ring, implant, and intrauterine forms of birth control.
-
With the inauguration of President Barack Obama and with expanded Democratic majorities in both chambers of Congress, reproductive health supporters in the administration, in Congress, and outside the government are entering the new year with renewed optimism.
-
Circle your calendar for the upcoming annual Contraceptive Technology Conferences. The San Francisco conference is scheduled for March 12-15, with the Washington, DC, conference set for March 26-29.
-
The Washington, DC-based National Abortion Federation (NAF) has launched the first interactive on-line continuing medical education (CME) program to allow health care providers to learn more about mifepristone.